c c c c c c c
tal Hygienist 9th Edition
c c c
by Elena Bablenis Haveles, Chapters 1 - 26 A+
c c c c c c c c
,Chapter 01: Information Sources, Regulatory Agencies, Drug Legislation, and PrescriptionWriting
c c c c c c c c c c
Haveles: Applied Pharmacology for the Dental Hygienist, 9th Edition
c c c c c c c c
MULTIPLEcCHOICE
1. Knowledgecofcpharmacologycaidscthecdentalcprofessionalcin
a. obtainingcacpatient’schealthchistory.
b. administeringcdrugscincthecoffice.
c. handlingcemergencycsituations.
d. selectioncofcacnonprescriptioncmedication.
e. Allcofcthecabove.
ANSWER:cE
Allcofcthecchoicescarectrue.cBecausecmanycofcourcpatientscarecbeingctreatedcwithcdrugs,cknowledgecofcpha
rmacologychelpscincunderstandingcandcinterpretingcpatients’cresponsesctochealthchistorycquestions.cKnow
ledgecofcthectherapeuticcandcadverseceffectscofcmedicationscobviouslychelpscinctheircpropercadministratio
ncincthecoffice.cEmergencycsituationscmaycbeccausedcbycdrugscorctreatedcbycdrugs;cthus,cknowledgecofcph
armacologyciscofcgreatchelp,cespeciallycbecausecacrapidcresponseciscsometimescrequired.cAcclearcunderst
andingcofcthecconceptscofcdrugcaction,cdrugchandlingcbycthecbody,candcdrugcinteractionscwillcallowcthecde
ntalcpractitionerctocmakecpropercjudgmentscandcgraspcthecconceptscrelevantctocnewcdrugctherapiesconcthec
market.
DIF: Application
REF:c RolecofcthecDentalcHygienistc(Medication/HealthcHistory),cRolecofcthecDentalcHygienistc(MedicationcA
dministration),cRolecofcthecDentalcHygienistc(EmergencycSituations),cRolecofcthecDentalcHygienistc(Nonpres
criptioncMedication)c|cpp.c2-3 OBJ: 1
TOP:c NBDHE,c6.0.cPharmacology
2. Whichcofcthecfollowingcstatementscisctruecregardingcplanningcappointments?
a. Whethercorcnotcpatientscarectakingcmedicationcforcsystemiccdiseasesciscofclittle
consequencecincthecdentalcoffice.
b. Asthmaticcpatientscshouldchavecdentalcappointmentscincthecmorning.
c. Diabeticcpatientscusuallychavecfewercproblemscwithcacmorningcappointment
comparedcwithcafternooncappointments.
d. BothcBcandcCcarectrue.
ANSWER:cD
Asthmaticcpatientscwhocexperiencecdentalcanxietycshouldcschedulectheircappointmentscwhenctheycarecnotc
rushedcorcundercpressurecearlycincthecmorning.cDiabeticcpatientscusuallychavecrelativelycfewercproblemsc
withcacmorningcappointment.cPatientsctakingcmedicationcforcsystemiccdiseasescmaycrequirecspecialchandli
ngcincthecdentalcoffice.
, DIF: Comprehension
REF:c RolecofcthecDentalcHygienistc(AppointmentcScheduling)c|cp.c3cO
BJ:c 1 TOP:c NBDHE,c6.0.cPharmacology
3. Nutritionalcorcherbalcsupplements
a. carrycthecU.S.cFoodcandcDrugcAdministrationc(FDA)capprovalcforcdiseasecstates.
b. arecnotcdrugs.
c. canccausecadverseceffects.
d. willcnotcinteractcwithcothercdrugscthecpatientcmaycbectaking.
ANSWER:cC
Nutritionalcorcherbalcsupplementscarecquiteccapablecofccausingcadverseceffects.cThecmajoritycofcn
utritionalcorcherbalcsupplementscdocnotccarrycFDAcapprovalcforctreatingcdiseasecstates.cThesecsup
plementscarecdrugscandccanccausecadverseceffectscandcinteractcwithcdifferentcdrugs.
DIF:c Comprehension
REF:cRolecofcthecDentalcHygienistc(NutritionalcorcHerbalcSupplements)c|cp.c3cO
BJ:c 1 TOP:c NBDHE,c6.0.cPharmacology
4. Whichctypecofcdrugcnamecusuallycbeginscwithcaclowercasecletter?
a. Brandcname
b. Codecname
c. Genericcname
d. Tradecname
ANSWER:cC
Beforecanycdrugciscmarketed,citciscgivencacgenericcnamecthatcbecomescthec“official”cnamecofcthecdrug.cEac
hcdrugciscassignedconlyconecgenericcnamecselectedcbycthecU.S.cAdoptedcNamecCouncil,candcthecnamecisc
notccapitalized.cThecbrandcnameciscequivalentctocthectradecnamecandcisccapitalized.cAlthoughcthecbrandcna
mecisctechnicallycthecnamecofctheccompanycmarketingcthecproduct,cthisctermciscoftencusedcinterchangeablyc
withcthectradecname.cTheccodecnameciscthecinitialctermcusedcwithincacpharmaceuticalccompanyctocreferctoc
acdrugcwhilecitciscundergoingcinvestigationcandciscoftencaccombinationcofccapitalcletterscandcnumbers,cthe
cletterscrepresentingcancabbreviationcofctheccompanycname.
DIF: Comprehension
REF:cDrugcNamesc|cp.c4cOBJ:c 3
TOP:c NBDHE,c6.0.cPharmacology
5. Acdrug’scgenericcnameciscselectedcbycthe
a. pharmaceuticalccompanycmanufacturingcit.
b. FoodcandcDrugcAdministrationc(FDA).
c. U.S.cAdoptedcNamecCouncil.
d. FederalcPatentcOffice.
, ANSWER:cC
Eachcdrugciscassignedconlyconecgenericcnamec(e.g.,cibuprofen).cItciscselectedcbycthecU.S.cAdoptedcNamec
Council.cThecgenericcnameciscnotcselectedcbycthecFDAcorcthecFederalcPatentcOffice.cThecpharmaceuticalc
companycmanufacturingcthecdrugcclearlychascancinfluenceconcthecgenericcnamecgivencitscdrug,cbutcthecfina
lcdecisionciscnotctheccompany’s.
DIF: Recall REF:c DrugcNamesc|cp.c4
OBJ:c 3cTOP:c NBDHE,c6.0.cPharmacology
6. Whichcofcthecfollowingcisctruecconcerningcgenericcandctradecnamescofcdrugs?
a. Acdrugcmayconlychaveconecgenericcnamecandconectradecname.
b. Acdrugcmayconlychaveconecgenericcname,cbutcitcmaychavecseveralctradecnames.
c. Acdrugcmaychavecseveralcgenericcnames,cbutcitcmayconlychaveconectradecname.
d. Acdrugcmaychavecseveralcgenericcnamescandcseveralctradecnames.
ANSWER:cB
Eachcdrugchasconlyconecgenericcnamecbutcmaychavecseveralctradecnames.cForceachcdrug,ctherecisconlyconec
genericcname.cItciscnotccapitalized,candcitcbecomescthec“official”cnamecofcthecdrug.cThecpharmaceuticalcc
ompanycdiscoveringcthecdrugcgivescthecdrugcactradecname.cThectradecnameciscprotectedcbycthecFederalcPat
entcLawcforc20cyearscfromcthecearliestcclaimedcfilingcdate,cpluscpatentctermcextensions.cAlthoughcthecbrand
cnamecisctechnicallycthecnamecofctheccompanycmarketingcthecproduct, citciscoftencusedcinterchangeablycwith
cthectradecname.
DIF: Comprehension
REF:cDrugcNamesc|cp.c4cOBJ:c 3
TOP:c NBDHE,c6.0.cPharmacology
7. Twocdrugscthatcarecfoundctocbecchemicallycequivalent,cbutcnotcbiologicallycequivalentcorcth
erapeuticallycequivalentcarecsaidctocdiffercin
a. potency.
b. efficacy.
c. bioavailability.
d. therapeuticcindex.
ANSWER:cC
Acpreparationccancbecchemicallycequivalentcyetcnotcbiologicallycorctherapeuticallycequivalent.cThesecpr
oductscarecsaidctocdiffercinctheircbioavailability.cThecpotencycofcacdrugciscacfunctioncofcthecamountcofcdrugc
requiredctocproducecanceffect.cThecefficacyciscthecmaximumcintensitycofceffectcorcresponsecthatccancbecpr
oducedcbycacdrug.cThectherapeuticcindexciscthecratiocofctheclethalcdosecforc50%cofcthecexperimentalcanim
alscdividedcbyctheceffectivecdosecforc50%cofcthecexperimentalcanimals.cIfcthecvaluecofcthectherapeuticcind
exciscsmall,ctoxicityciscmoreclikely.
DIF: Recall
REF:c DrugcNamesc(DrugcSubstitution)c|cp.c5cOBJ:c 4
TOP:c NBDHE,c6.0.cPharmacology